Clinical Trials in Ohio

Showing 9581-9600 of 20,938 trials

An Extension of the TG1101-RMS201 Trial

NCT03381170

This study evaluates the long term use of a single agent ublituximab, a novel monoclonal antibody, in patients with relapsing forms of multiple sclerosis

Relapsing Remitting Multiple Sclerosis

TG Therapeutics, Inc.48 participantsStarted Jun 2017

Pasadena, California, United States • Aurora, Colorado, United States • Lexington, Kentucky, United States +5 more locations

COMPLETEDPhase 232 miles

A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics

NCT04663282

The study is being conducted to evaluate the efficacy and safety of IND068 once daily (QD) in subjects with type 2 diabetes not adequately controlled with one or two oral antidiabetics compared to insulin degludec QD for 16 weeks.

Type 2 Diabetes

Jiangsu HengRui Medicine Co., Ltd.179 participantsStarted Feb 2021

Huntington Park, California, United States • Lincoln, California, United States • Lomita, California, United States +32 more locations

An Extension of the TG1101-RMS201 Trial

A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics

Find Trials by Condition in Ohio

An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis

A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma

AeroVanc in the Treatment of Methicillin-resistant Staphylococcus Aureus Infection in Patients With Cystic Fibrosis

A Study of the Effect of Topical Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism

The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System

Exalenz Lab Mode System Compared to Biopsy for H.Pylori Detection

Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis

Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States

Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic Decompensation

Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori

A Study to Evaluate the Efficacy and Safety of CEP-33457 in Participants With Systemic Lupus Erythematosus (SLE)

An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosus

Formula Tolerance of Term Infants

Integrated Stepped Care for Unhealthy Alcohol Use in HIV

VIBRANT Study of Vurolenatide in Adult Patients With Short Bowel Syndrome.

Treatment of SARS-CoV-2 Virus Disease (COVID-19) in Humans With Hemopurifier® Device

ESTIA: Computerized Intervention Targeting Cognitive Control Deficits in Depressed Adults

A Study Evaluating the Efficacy of Venetoclax Plus Ibrutinib in Participants With T-cell Prolymphocytic Leukemia